Related Experiment Video
Updated: Mar 3, 2026

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
Elevated PGE2 and COX-2 expression in villous adenoma: Implications for electrolyte depletion syndrome
Shiki Fujino1,2, Hiroyuki Fukuda1, Katsuki Danno1
1Department of Surgery, Minoh City Hospital, Minoh, Osaka 562-0014, Japan.
Abstract:
The present study aimed to clarify the role of prostaglandin E2 (PGE2) signaling in the pathogenesis of electrolyte depletion syndrome (EDS) in colorectal villous adenomas (VAs), which are characterized by excessive mucus secretion and higher malignant potential compared with tubular adenomas (TAs). A retrospective analysis was conducted on 40 colorectal adenoma cases (20 VAs and 20 TAs) resected between January 2011 and September 2021. Clinicopathological factors such as age, sex, tumor location and size were compared. In addition, immunohistochemical staining for PGE2, COX-1 and COX-2 was performed, and the percentage of positive glands was quantified. Associations between PGE2 and COX isoform expression were then analyzed. The results revealed that VAs were more prevalent in female patients (P=0.022) and exhibited a significantly larger tumor size than TAs (21.3±22.5 mm vs. 9.6±7.8 mm, P=0.018). Furthermore, PGE2 and COX-2 expression were significantly elevated in VAs compared with in TAs (P<0.001 and P=0.022, respectively), whereas COX-1 levels were similar. In VAs, PGE2 expression was weakly-to-moderately associated with COX-1 and associated with COX-2 (trend), whereas no associations were observed in TAs. In conclusion, PGE2 upregulation may contribute to EDS in VAs, underscoring the need for early recognition and targeted therapeutic approaches.
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

